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Content 
1. Preimplantation embryo development is dynamic and responsive to external 
signals, conferring ‘plasticity’ in form or phenotype   
2. Preimplantation embryos sense and adapt to their environment either in vivo 
dependent upon maternal nutrition and lifestyle or in response to in vitro 
culture  
3. Embryonic responses are beneficial in the short-term to ensure survival and 
optimal developmental progression yet increase the risk of ill health later in 
life through to adulthood 
 
Objectives 
1. To be aware that maternal nutrition or in vitro environment influence 
embryonic development, gene expression and metabolism 
2. To acknowledge mechanisms by which the preimplantation embryo can sense 
and react to the environment it develops in  
3. To understand the concept that developmental plasticity is advantageous to 
maximise survival chances at an increased risk of later disease should 
prevailing conditions change 
 
Ethical issues 
1. Can we blame our parents for ill health in the next generation? 
2. How can effective interventions to suppress disease risk be developed and 
tested? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
The environment profoundly affects the developing conceptus. Observations in the 
human and experimental data derived from various animal models provide 
insurmountable evidence for this concept (eg 1-3). In an evolutionary context, such a 
concept would make sense as predictive adaptations to the environment anticipated 
later in life would confer a competitive advantage and benefit survival to reproductive 
age. However, should predictions be wrong and prevailing conditions change, the 
individual becomes ‘maladapted’ and increased risk of adult onset diseases will result, 
particulary metabolic syndrome, diabetes and cardiovascular dysfunction (1). 
Supporting evidence for this concept of matching or mis-matching environments 
comes from animal data. For example, in rodent models, maternal undernutrition 
exclusively during the preimplantation period followed by switching back to normal 
nutrition thereafter ‘tricks’ the embryo into making the wrong responses, preparing 
for a deprived environment. As a consequence, fetal and postnatal overgrowth and 
associated metabolic and cardiovascular problems follow (4-6). Different 
developmental periods have shown varying sensitivity to environmental cues and the 
preimplantation period is amongst the most sensitive. 
 
The preimplantation period 
The preimplantation period encompasses the time from fertilisation to blastocyst 
development (Figure 1) when cells undergo the transition from being totipotent to 
their first differentiation before the embryo implants into the uterus. During this 
period, the embryo undergoes a number of key transitions: 1) switching from 
development regulated by maternally inherited proteins and mRNA messages to 
embryonic control by activating the newly formed embryonic genome; 2) 
morphological re-organisation and the first cell specification into inner cell mass 
(ICM, giving rise to the embryo proper) and trophectoderm (TE, giving rise to 
extraembryonic lineages such as placenta); 3) a change of metabolic and nutrient 
preferences; 4) preparation for implantation by signalling at the materno-embryonic 
interface and developing an invasive phenotype (3,7).  
 
Developmental plasticity and environmental challenges 
It has become clear that the developmental processes mentioned above are dynamic 
events allowing for a high degree of developmental plasticity rather than following a 
pre-determined static ‘programme’. For example, it has long been observed that 
embryos taken out of their normal in vivo environment within the mother and placed 
into in vitro culture delay their developmental progress and change their gene 
expression and metabolic profiles according to the in vitro conditions (8). However, 
depending on the species, most still retain their capacity to implant and continue 
developing into viable offspring after transfer back into the mother.  
 
In vitro culture media usually only consist of a buffered salt solution with a limited 
diversity of nutrient and growth factor supplements. Thus, it could be argued that in 
vitro culture is a very drastic change in what the embryo is provided with compared to 
the ‘normal’ conditions in vivo and, therefore, not being physiologically relevant. 
Given that around 12,500 children (HFEA, 2006) are currently born each year from 
infertility treatment in the UK alone, does exposure to in vitro conditions at this 
sensitive period in development cause reason for concern? Since most assisted 
conception children have not yet reached adulthood and follow-up studies are limited, 
it is difficult to reach a firm conclusion. However, a number of reports on increased 
birth defects and altered metabolic and cardiovascular physiology associated with 
IVF/ICSI treatments have been published (2,9,10) (Box 1). More recently, animal 
models show that more subtle environmental changes such as, for example, slightly 
altering single media supplements in vitro or specific maternal diets or body 
conditions in vivo, also influence development and adverse adult outcomes (4-6,11-
13). Such developmental plasticity underlies the biological principle of adaptive 
responses to predicted conditions. Measurable changes can become evident before 
implantation and may be transient or long-lasting.  
 
Developmental plasticity of the preimplantation embryo 
It is now clear that despite not yet being in direct contact with maternal systemic 
blood supply, the preimplantation embryo is able to sense and react to environmental 
cues, adapting to prevailing conditions. Underlying mechanisms are still subject to 
intense investigation (Figure 2). In the preimplantation embryo, processes known to 
adapt to various environmental cues include cell lineage distribution between ICM 
and TE in the blastocyst (4,13), mitochondrial function (13,14), cellular energy 
sensors and signalling system sensitivity (AMPK, mTOR, 15 ), metabolism (eg amino 
acid turnover, carbohydrate metabolism 13,16,17) and nutrient transport (7). At 
mRNA level, an even larger array of cell functions and cellular pathways have been 
identified to be influenced by environmental cues (reviewed in 8).  
 
Why is the preimplantation embryo so sensitive to its environment? 
At one level, the preimplantation embryo is likely to be sensitive to environmental 
cues as it only consists of a small number of cells which will give rise to all the tissues 
of the conceptus later on; this finite pool of cells is therefore vulnerable by virtue of 
their limited supply and essential future contribution. Secondly, putting it simply, the 
preimplantation embryo’s main task is to generate two pools of cells capable of 
forming the embryo (future fetal) and placental components of the conceptus.  From 
an evolutionary perspective, it would be an advantage for these early cells to have a 
‘blue-print’ of the necessary growth and phenotypic characteristics required for fetal 
and placental components to function optimally in the nutritional environmental 
circumstances that the mother finds herself in. It appears likely, therefore, that optimal 
functioning, can be better regulated early by the way it is constructed from the 
blastocyst stage onwards rather than by later modification to an existing structural 
organisation.  However, if early development possesses a high degree of plasticity, 
why does it not revise adaptations if and when the environmental circumstances 
change? It is possible that this is exactly what happens for many cells so that 
adaptations become limited to specific tissue and organ systems rather than 
necessarily affecting the whole organism. Another major question is how 
environmental changes experienced by cells only during the preimplantation period 
might be ‘memorised’ and lead to long-term changes in the phenotype of derivative 
cells later in development or after birth? The answer appears to reside in a rapidly 
moving research area, that of epigenetics (see below) and provides a third reason why 
preimplantation embryos might be vulnerable to their environment.  
 
Epigenetic mechanisms 
All cells within the body have the same genetic make-up. Which genes are expressed 
and which ones are silenced is, at least in part, regulated by chemical modifications to 
the chromatin, so-called epigenetic mechanisms (reviewed in 18). Epigenetic switches 
control gene activity in a tissue-specific manner. Stable epigenetic marks such as 
DNA CpG methylation are inherited by the daughter cells across the cell cycle. 
Within the early preimplantation embryo such stable epigenetic marks are mostly 
erased before being gradually re-established upon cavitation into the blastocyst in a 
lineage-specific manner. How long epigenetic control stays flexible is subject to 
debate and, most likely, depends on the specific gene, its activity and function, and, 
potentially, on the external cues experienced. Overall, it is conceivable that both, 
transient and more permanent epigenetic deregulation could easily occur during the 
preimplantation period. Such a deregulation would be likely to have widespread 
consequences across different tissue types and organs since it happened at a stage 
when one cell would still give rise to a large part of an organism. Consistent with this 
idea it has been shown in in vitro culture or diet models that organs from all three 
germ layers and extraembryonic lineages (placenta) can display altered expression of 
specific genes coinciding with changes in promoter methylation (12,19-21). 
 
How can we interfere with this biological principle? 
Finally, the question arises, can we prevent or intervene with adverse developmental 
programming, and if so, when do we need to do this? Since the detailed knowledge 
about underlying mechanisms is still only emerging suggesting a number of different 
drug target candidates, little is known about effective intervention or prevention 
strategies. First evidence that prevention is possible is derived from animal studies 
whereby some of the postnatal phenotypes could be alleviated by supplementing a 
maternal low-protein diet with folic acid, a methyl-group donor (22). Given the global 
effect such a treatment could have on DNA methylation patterns, this can just be 
viewed as a proof-of-principle approach and more targeted interventions are required. 
It is also likely to be of limited value for reversing already established alterations once 
they have stabilised. Other examples are postnatal treatment with leptin, growth 
hormone or statins (23-25) which could alleviate adverse offspring phenotypes after 
maternal dietary challenge in animal models. 
 
Future directions 
Insurmountable evidence now confirms the biological principle that life experiences 
in utero provoke responses to prevailing conditions in the developing organism. Such 
adaptations already occur during the preimplantation period before a woman knows 
she is pregnant. Although these adaptations are beneficial in the short-term enabling 
the best possible start into life, they can come at a cost of compromised later health. 
Given the global trend of an ageing human population, this may present the medical 
profession with a considerable burden in the future. A global effort is required by 
scientists, medical professions and political decision makers to work together to 
develop strategies to tackle such a worldwide health risk. Such strategies will also 
have to address ethical issues arising from the concept that parental lifestyle 
experiences and choices can profoundly impact on the health of the next generation. 
The old adage that a pregnant mother eats for two has taken on new meaning and 
especially around the time of conception.  
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Figure legends 
 
Figure 1: 
Human preimplantation embryos. After fertilisation and cleavage, blastomeres flatten 
during compaction before segregation into inner cell mass and trophectoderm at 
cavitation to the blastocyst. 
 
Figure 2: 
Environmental influence on the preimplantation embryo. In vitro conditions or 
maternal influences in vivo formulate environmental cues the embryo adapts to 
utilising different mechanisms. This developmental plasticity confers an advantage in 
the short-term but can have long-term adverse consequences into later development 
and adult life. 
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BOX 1: Examples of offspring phenotype in response to preimplantation 
environmental cues 
 
IVF children  
Increased systolic and diastolic blood pressure 
Increased fasting glucose 
Increased DHEAS and LH concentrations in girls 
Increased late infancy growth with altered serum profiles 
Perturbed body fat composition 
Thyroid dysfunction 
Increased risk of imprinting disorders is debated 
Impact on behaviour and neuromotor development is debated 
No effect apparent on allergies 
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Maternal diet or in vitro culture animal models 
Increased blood pressure (Kwong, Watkins, Sinclair) 
Increased anxiety-related behaviour (Ecker, Watkins) 
Increased obesity risk (Watkins) 
Decreased insulin sensitivity (Sinclair) 
Altered immune function (Sinclair)  
Animal Rerences: 
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